Indian Army Pharmaceuticals Tender 2026 for Multiple Tablets and Oncology Agents - 328331 INR Estimated Value 2026

Tender Overview

The Indian Army invites bids for a procurement package of multiple tablets and oncology-related drugs across 21 items, with an estimated value of ₹328,331. The scope covers a broad range of medicines such as Gimeracil/Temozolomide combinations, Letrozole, Sorafenib, Lenvatinib, Lenalidomide, and Tamoxifen, among others. Deliverables will target government hospital supply needs, with emphasis on maintaining shelf life and traceability. The tender stresses OEM authorizations, exact product specifications, and barcoding via specific software to ensure compliant distribution. The procurement emphasizes reliability, standardization, and compatibility with hospital inventory systems. A unique differentiator is the mandatory integration with the Dhanwantari software platform for registration and barcode generation. The opportunity is framed for suppliers with strong compliance and product traceability capabilities. Unique clauses highlight shelf life thresholds, supplier authorization, and invoicing requirements.

Technical Specifications & Requirements

• Exact product names include a spectrum of chemotherapeutic and anti-estrogen medications: Tab Tegafur with Gimeracil and Oteracil, Temozolamide 100 mg, Tamoxifen 20 mg, Sorafenib 200 mg, Relugolix 120 mg, Pomalidomide 4 mg, Nintedanib 150 mg and 100 mg, Letrozole 2.5 mg, Lenvatinib 4 mg, Lenalidomide 5 mg, Hydroxyurea 500 mg, Gefitinib 250 mg, Erlotinib 150 mg, Dasatinib 50 mg, Cabozatinib 40 mg, Bicalutamide 50 mg, Anastrozole 1 mg.
• Quantity/Volume: 21 items listed; exact quantities are not disclosed in the BOQ.
• Delivery/Charting: Barcodes on all delivered items; Dhanwantari software registration required; OEM authorization certificates mandatory for all quoted products; invoices to be produced at delivery; shelf life criteria apply.
• Standards & Compliance: Specific shelf-life cutoffs; whether these drugs must be Indian-origin with 56% remaining shelf life or imported-origin with 23% remaining shelf life.
• Quality & Traceability: Exact product specifications and manufacturer details to be uploaded; registration screenshot to be uploaded.
• Logistics: Goods delivery to hospital; mandatory barcode generation and invoicing documents.

Terms, Conditions & Eligibility

• Shelf life compliance: Indian-origin products require ≥56% remaining shelf life; imported-origin ≥23% remaining shelf life.
• OEM authorization: Certificates required for all quoted products; failure results in technical disqualification.
• Dhanwantari software: Bidder must upload registration screenshot; barcode generation is mandatory.
• Invoicing: Purchase invoice must be produced at the time of delivery; non-compliance leads to rejection.
• Delivery option clause: Quantity adjustments up to 25% during contract; delivery timelines adapt accordingly with minimum 30 days baseline.
• Acceptance & penalties: Not explicitly listed; bidders must ensure shelf life, barcoding, and invoice provisions are satisfied.